PCSK9: from biology to clinical applications

作者: Valentin Blanchard , Ilya Khantalin , Stéphane Ramin-Mangata , Kévin Chémello , Brice Nativel

DOI: 10.1016/J.PATHOL.2018.10.012

关键词:

摘要: … safety aspects in the development of PCSK9 inhibitors. Mendelian randomisation studies have recently corroborated the causal relationship between PCSK9, LDL-C and cardiovascular …

参考文章(75)
Shia T Kent, Robert S Rosenson, Christy L Avery, Yii-Der I Chen, Adolfo Correa, Steven R Cummings, L Adrienne Cupples, Mary Cushman, Daniel S Evans, Vilmundur Gudnason, Tamara B Harris, George Howard, Marguerite R Irvin, Suzanne E Judd, J Wouter Jukema, Leslie Lange, Emily B Levitan, Xiaohui Li, Yongmei Liu, Wendy S Post, Iris Postmus, Bruce M Psaty, Jerome I Rotter, Monika M Safford, Colleen M Sitlani, Albert V Smith, James D Stewart, Stella Trompet, Fangui Sun, Ramachandran S Vasan, J Michael Woolley, Eric A Whitsel, Kerri L Wiggins, James G Wilson, Paul Muntner, None, PCSK9 Loss-of-Function Variants, Low-Density Lipoprotein Cholesterol, and Risk of Coronary Heart Disease and Stroke: Data From 9 Studies of Blacks and Whites. Circulation-cardiovascular Genetics. ,vol. 10, ,(2017) , 10.1161/CIRCGENETICS.116.001632
Nathalie Bergeron, Binh An P. Phan, Yunchen Ding, Aleyna Fong, Ronald M. Krauss, New Drugs and Technologies Circulation. ,(2015) , 10.1161/CIRCULATIONAHA.115.016080
Clapton S. Dias, Adam J. Shaywitz, Scott M. Wasserman, Brian P. Smith, Bing Gao, Dina S. Stolman, Caroline P. Crispino, Karen V. Smirnakis, Maurice G. Emery, Alexander Colbert, John P. Gibbs, Marc W. Retter, Blaire P. Cooke, Stephen T. Uy, Mark Matson, Evan A. Stein, Effects of AMG 145 on low-density lipoprotein cholesterol levels: results from 2 randomized, double-blind, placebo-controlled, ascending-dose phase 1 studies in healthy volunteers and hypercholesterolemic subjects on statins. Journal of the American College of Cardiology. ,vol. 60, pp. 1888- 1898 ,(2012) , 10.1016/J.JACC.2012.08.986
Binh An P. Phan, Nathalie Bergeron, Ronald M. Krauss, Yunchen Ding, Aleyna Fong, Proprotein convertase subtilisin/kexin type 9 inhibition: a new therapeutic mechanism for reducing cardiovascular disease risk. Circulation. ,vol. 132, pp. 1648- 1666 ,(2015) , 10.1161/CIRCULATIONAHA.115.016080
R. E. Hammer, Y.-A. Moon, J. D. Horton, S. Rashid, D. E. Curtis, R. Garuti, N. N. Anderson, Y. Bashmakov, Y. K. Ho, Decreased plasma cholesterol and hypersensitivity to statins in mice lacking Pcsk9 Proceedings of the National Academy of Sciences of the United States of America. ,vol. 102, pp. 5374- 5379 ,(2005) , 10.1073/PNAS.0501652102
Rossi P. Naoumova, Isabella Tosi, Dilip Patel, Clare Neuwirth, Stuart D. Horswell, A. David Marais, Charles van Heyningen, Anne K. Soutar, Severe Hypercholesterolemia in Four British Families With the D374Y Mutation in the PCSK9 Gene: Long-Term Follow-Up and Treatment Response Arteriosclerosis, Thrombosis, and Vascular Biology. ,vol. 25, pp. 2654- 2660 ,(2005) , 10.1161/01.ATV.0000190668.94752.AB
J. C. Y. Chan, D. E. Piper, Q. Cao, D. Liu, C. King, W. Wang, J. Tang, Q. Liu, J. Higbee, Z. Xia, Y. Di, S. Shetterly, Z. Arimura, H. Salomonis, W. G. Romanow, S. T. Thibault, R. Zhang, P. Cao, X.-P. Yang, T. Yu, M. Lu, M. W. Retter, G. Kwon, K. Henne, O. Pan, M.-M. Tsai, B. Fuchslocher, E. Yang, L. Zhou, K. J. Lee, M. Daris, J. Sheng, Y. Wang, W. D. Shen, W.-C. Yeh, M. Emery, N. P. C. Walker, B. Shan, M. Schwarz, S. M. Jackson, A proprotein convertase subtilisin/kexin type 9 neutralizing antibody reduces serum cholesterol in mice and nonhuman primates. Proceedings of the National Academy of Sciences of the United States of America. ,vol. 106, pp. 9820- 9825 ,(2009) , 10.1073/PNAS.0903849106
Derek E. Piper, Simon Jackson, Qiang Liu, William G. Romanow, Susan Shetterly, Stephen T. Thibault, Bei Shan, Nigel P.C. Walker, The Crystal Structure of PCSK9: A Regulator of Plasma LDL-Cholesterol. Structure. ,vol. 15, pp. 545- 552 ,(2007) , 10.1016/J.STR.2007.04.004
Nidhi Gupta, Niels Fisker, Marie-Claude Asselin, Marie Lindholm, Christoph Rosenbohm, Henrik Ørum, Joacim Elmén, Nabil G. Seidah, Ellen Marie Straarup, A Locked Nucleic Acid Antisense Oligonucleotide (LNA) Silences PCSK9 and Enhances LDLR Expression In Vitro and In Vivo PLoS ONE. ,vol. 5, pp. e10682- ,(2010) , 10.1371/JOURNAL.PONE.0010682
Evan A. Stein, Scott Mellis, George D. Yancopoulos, Neil Stahl, Douglas Logan, William B. Smith, Eleanor Lisbon, Maria Gutierrez, Cheryle Webb, Richard Wu, Yunling Du, Therese Kranz, Evelyn Gasparino, Gary D. Swergold, Effect of a Monoclonal Antibody to PCSK9 on LDL Cholesterol The New England Journal of Medicine. ,vol. 366, pp. 1108- 1118 ,(2012) , 10.1056/NEJMOA1105803